News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
35,689 Results
Type
Article (2823)
Company Profile (4)
Press Release (32862)
Multimedia
Podcasts (10)
Webinars (1)
Section
Business (7961)
Career Advice (65)
Deals (1250)
Drug Delivery (2)
Drug Development (5184)
Employer Resources (4)
FDA (910)
Job Trends (791)
News (15477)
Policy (1520)
Tag
Academia (161)
Accelerated approval (7)
Allergies (15)
Alliances (2235)
ALS (10)
Alzheimer's disease (96)
Antibody-drug conjugate (ADC) (30)
Approvals (920)
Artificial intelligence (24)
Autoimmune disease (10)
Automation (1)
Bankruptcy (9)
Best Places to Work (697)
Biosimilars (6)
Biotechnology (4)
Bladder cancer (24)
Brain cancer (5)
Breast cancer (48)
Cancer (502)
Cardiovascular disease (32)
Career advice (60)
Career pathing (1)
CAR-T (19)
CDC (3)
Cell therapy (48)
Clinical research (4502)
Collaboration (78)
Compensation (26)
Complete response letters (3)
COVID-19 (177)
CRISPR (1)
C-suite (42)
Cystic fibrosis (1)
Data (608)
Denatured (7)
Depression (6)
Diabetes (42)
Diagnostics (382)
Digital health (4)
Diversity (4)
Diversity, equity & inclusion (1)
Drug discovery (9)
Drug pricing (8)
Duchenne muscular dystrophy (8)
Earnings (2783)
Editorial (5)
Employer resources (3)
Events (7979)
Executive appointments (45)
FDA (1101)
Funding (64)
Gene editing (8)
Generative AI (2)
Gene therapy (33)
GLP-1 (75)
Government (282)
Guidances (21)
Healthcare (953)
HIV (8)
Huntington's disease (1)
Immunology and inflammation (18)
Immuno-oncology (2)
Indications (13)
Infectious disease (188)
Inflammatory bowel disease (9)
Influenza (1)
Intellectual property (9)
Interviews (14)
IPO (461)
IRA (2)
Job creations (124)
Job search strategy (46)
JPM (7)
Kidney cancer (6)
Layoffs (26)
Leadership (2)
Legal (340)
Liver cancer (2)
Lung cancer (93)
Lymphoma (44)
Machine learning (1)
Management (1)
Manufacturing (39)
MASH (20)
Medical device (500)
Medtech (502)
Mergers & acquisitions (828)
Metabolic disorders (89)
Multiple sclerosis (18)
NASH (7)
Neurodegenerative disease (21)
Neuropsychiatric disorders (3)
Neuroscience (183)
NextGen: Class of 2026 (352)
Non-profit (281)
Now hiring (2)
Obesity (26)
Opinion (11)
Ovarian cancer (8)
Pain (3)
Pancreatic cancer (22)
Parkinson's disease (24)
Partnered (1)
Patents (12)
Patient recruitment (33)
Peanut (5)
People (2542)
Pharmaceutical (3)
Phase 1 (1293)
Phase 2 (1812)
Phase 3 (1844)
Pipeline (301)
Policy (17)
Postmarket research (176)
Preclinical (660)
Prostate cancer (49)
Psychedelics (2)
Radiopharmaceuticals (91)
Rare diseases (44)
Real estate (271)
Recruiting (2)
Regulatory (1158)
Reports (2)
Research institute (139)
Resumes & cover letters (10)
Schizophrenia (7)
Series A (7)
Series B (4)
Sickle cell disease (9)
Spinal muscular atrophy (38)
Sponsored (2)
Startups (152)
State (1)
Supply chain (6)
Tariffs (1)
The Weekly (3)
Vaccines (42)
Venture capital (4)
Weight loss (19)
Women's health (10)
Date
Last 7 days (28)
Last 30 days (104)
Last 365 days (1766)
2026 (142)
2025 (1758)
2024 (1991)
2023 (2278)
2022 (2919)
2021 (2721)
2020 (2456)
2019 (2606)
2018 (1970)
2017 (1621)
2016 (1644)
2015 (2004)
2014 (1511)
2013 (1269)
2012 (1320)
2011 (1383)
2010 (1198)
Location
Africa (39)
Arizona (19)
Asia (2707)
Australia (379)
California (679)
Canada (122)
China (108)
Colorado (25)
Connecticut (16)
Delaware (26)
Europe (4195)
Florida (98)
Georgia (23)
Hawaii (1)
Idaho (5)
Illinois (76)
India (10)
Indiana (45)
Japan (30)
Kansas (3)
Kentucky (1)
Louisiana (1)
Maine (2)
Maryland (53)
Massachusetts (461)
Michigan (7)
Minnesota (32)
Missouri (8)
Nebraska (1)
Nevada (24)
New Hampshire (2)
New Jersey (210)
New Mexico (2)
New York (266)
North Carolina (63)
Northern California (385)
Ohio (24)
Oregon (1)
Pennsylvania (87)
Rhode Island (3)
South America (43)
South Carolina (2)
Southern California (198)
Tennessee (8)
Texas (97)
United States (2303)
Utah (4)
Virginia (9)
Washington State (35)
Wisconsin (12)
35,689 Results for "sun nuclear".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sun Nuclear to Highlight New Quality Management Solutions at 2025 AAPM Annual Meeting
July 25, 2025
·
4 min read
Press Releases
Sun Nuclear Acquires Oncospace, AI-Focused Radiation Oncology Software Provider
April 30, 2025
·
2 min read
Insights
From Nuclear Winter to Renewal: Biotech Investing for 2026
In this episode of Denatured, Jennifer C. Smith-Parker speaks to Maha Katabi, general partner at Sofinnova Investments and Andrew Lam, managing director, head of Biotech Private Equity at Ally Bridge Group, about how M &A dynamics, dealmaking and global partnerships are reshaping portfolio valuations and paths to growth in 2026.
January 8, 2026
·
1 min read
·
Jennifer Smith-Parker
Press Releases
Defence Therapeutics Expands Collaboration with Canadian Nuclear Laboratories to Accelerate Its Proprietary Radiopharmaceutical Pipeline
January 28, 2026
·
5 min read
BioMidwest
Sun Nuclear Showcases New Quality Management Solutions for Radiation Therapy Teams and Workflows at ESTRO Annual Meeting
Sun Nuclear, a Mirion Medical company, will feature new and enhanced solutions for better Quality Management at the ESTRO Annual Meeting, May 3-6, in Glasgow, Scotland.
May 3, 2024
·
4 min read
Mergers & acquisitions
At JPM26, Policy and Politics Will Loom Large for Pharma as Biotech Sees the Sun
Pharmas will need to provide their latest stance on the Most Favored Nation drug pricing plans, while biotech finally gets a break after a few tough years.
January 9, 2026
·
4 min read
·
Annalee Armstrong
Press Releases
Kazia Therapeutics Announces Compelling Preclinical and Translational Data for Nuclear PD-L1 Degrader (NDL2)
February 1, 2026
·
11 min read
Press Releases
Sun Pharma Announces the Availability of UNLOXCYT™ (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma (aCSCC)
January 16, 2026
·
8 min read
Press Releases
IBA acquires ORA expanding its strategic leadership in Nuclear Medicine
December 19, 2025
·
3 min read
Press Releases
Sun Pharma Canada Inc. Acquires Commercial Rights to LEVULAN® KERASTICK®
November 13, 2025
·
4 min read
1 of 3,569
Next
